ALL NEWS TODAY

[ ALL NEWS TODAY ]

ISTA Pharmaceuticals Announces New Phase III Clinical Findings To Support Bepreve NDA Filing

ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), announced positive results from the preliminary analysis of its second and final Bepreve(TM) (bepotastine ophthalmic solution) Phase III clinical study. The U.S. multi-center conjunctival allergen challenge (CAC) study evaluated the onset and duration of effect of two Bepreve concentrations in 130 patients with a history of ocular allergies.
Comments: [0] / Post comment:
03 Dec 2008 01:01:06

Shipping fragile fossils - Packaging Digest

Shipping fragile fossils Packaging Digest, IL - He assembled a team of packaging experts from Sealed Air, the International Safe Transit Association ISTA (www. ista .org) , Lansmont Corp. ...
30 Nov 2008 01:11:33

Blutigeroo leads Victorian raiders - The Canberra Times

Blutigeroo leads Victorian raiders The Canberra Times, Australia - Blutigeroo will headline a two-pronged assault on Canberra's premier staying event from Little's Caulfield stable, joining Ista Kareem in the $200000 ...
28 Nov 2008 23:20:06

Hotels to go in for tougher security measures - Times of India

Hotels to go in for tougher security measures Times of India, India - Senior officials of The Leela Group, The ITC Group, The Lalit Group and the Ista chain of hotels told TOI that their respective managements are looking at ... Hotels make room for everybody
26 Nov 2008 09:17:10

MCS board debates rising cost of health insurance - Chronicle-Tribune

MCS board debates rising cost of health insurance Chronicle-Tribune, IN - Steve Wise, representative for ISTA , said the teachers would see a 3.5 percent increase compared to market rate increases of about 10 percent to 13 percent ...
25 Nov 2008 13:16:08

Learn about the World Ophthalmic Pharmaceutical Drugs Market - MarketWatch

Learn about the World Ophthalmic Pharmaceutical Drugs Market MarketWatch - ... II-68 Alimera Conducts Phase III Medidur Trial II-68 ISTA Pharmaceuticals Files NDA for Xibrom(TM) QD II-68 AzaSite Receives FDA Approval II-68 Alimera ...
21 Nov 2008 18:59:59

Updated FDA Calendar of 75 Decision Dates - Motley Fool

Updated FDA Calendar of 75 Decision Dates Motley Fool - Some other recent filings include Ista Pharma's ( ISTA ) NDA for eye drop Bepreve and two new filings by Johnson & Johnson (JNJ) for Comfyde and trabectedin.
19 Nov 2008 01:08:21

Ista Kareem In Demand - Racing and Sports Pty Ltd

Racing and Sports Pty Ltd Ista Kareem In Demand Racing and Sports Pty Ltd, Australia - Wednesday, 19 November 2008: Smart punters with an eye on the weather have rallied behind the Colin Little-trained stayer Ista Kareem to win today's $200000 ... Little Pins Hope On Rain In Ballarat Cup Banana Man double shake
14 Nov 2008 15:30:16

Ista a definite starter for Little's Kareem - Ballarat Courier

Ista a definite starter for Little's Kareem Ballarat Courier, Australia - CAULFIELD trainer Colin Little has declared Ista Kareem a definite starter in the $121000 BMW Ballarat Cup, 2200 metres, on Wednesday. ... Door still ajar for top weight
14 Nov 2008 11:48:40

OTCPicks.com: OTCPicks.com Stocks to Watch for Friday, November ... - Trading Markets (press release)

OTCPicks.com: OTCPicks.com Stocks to Watch for Friday, November ... Trading Markets (press release), CA - ISTA Pharmaceuticals is an ophthalmic pharmaceutical company. ISTA's products and product candidates addressing the $4.7 billion US prescription ophthalmic ... Anviron Reports October Financial Results up 157% over Budget Anviron Reports October Financial Results up 157% over Budget
13 Nov 2008 23:01:25

ISTA Pharmaceuticals Files New Drug Application with US FDA for ... - SYS-CON Brasil

ISTA Pharmaceuticals Files New Drug Application with US FDA for ... SYS-CON Brasil, NJ - ISTA filed the Bepreve NDA electronically, in eCTD format and using the FDA's Electronic Submission Gateway. Pending FDA validation of the electronic file ...

Keywords:

ALL NEWS TODAY © PoznaiSebya.Сom
Designer Dmytriev Dmytriy